Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Q/C Technologies, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 50 | 48 | −2 |
| Shares | 4.06M | 4.34M | +282.2K (+7.0%) |
| Value | $6.98M | $6.51M | −$469.1K (−6.7%) |
New holders (6)
Institutions that held Q/C Technologies, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 42,845 | $64.3K | 0.00% |
| HRT Financial LP | 14,815 | $22.0K | 0.00% |
| Walled Lake Planning & Wealth Management, LLC | 14,000 | $21.0K | 0.01% |
| Flow Traders U.S. LLC | 11,925 | $18.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 4,300 | $6.45K | 0.00% |
| Toronto Dominion Bank | 65 | $0 | 0.00% |
Sold out (8)
Institutions that held Q/C Technologies, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Wolverine Trading, LLC | 17,601 | $30.0K |
| Sawtooth Solutions, LLC | 10,000 | $17.2K |
| FMR LLC | 1,000 | $1.72K |
| JPMorgan Chase & Co | 347 | $1.00K |
| Advisory Services Network, LLC | 200 | $344 |
| Strategic Investment Solutions, Inc. | 200 | $344 |
| Northwestern Mutual Wealth Management Co | 74 | $127 |
| GWM Advisors LLC | 1 | $2 |